Mostrar el registro sencillo del ítem
Pre-Diagnostic Circulating Resistin Concentrations Are Not Associated with Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Study
dc.contributor.author | Pham, Thu Thi | |
dc.contributor.author | Sánchez Pérez, María José | |
dc.date.accessioned | 2022-12-12T12:47:27Z | |
dc.date.available | 2022-12-12T12:47:27Z | |
dc.date.issued | 2022-11-09 | |
dc.identifier.citation | Pham, T.-T... [et al.]. Pre-Diagnostic Circulating Resistin Concentrations Are Not Associated with Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Study. Cancers 2022, 14, 5499. [https://doi.org/10.3390/cancers14225499] | es_ES |
dc.identifier.uri | https://hdl.handle.net/10481/78400 | |
dc.description.abstract | Resistin is a polypeptide implicated in inflammatory processes, and as such could be linked to colorectal carcinogenesis. In case-control studies, higher resistin levels have been found in colorectal cancer (CRC) patients compared to healthy individuals. However, evidence for the association between pre-diagnostic resistin and CRC risk is scarce. We investigated pre-diagnostic resistin concentrations and CRC risk within the European Prospective Investigation into Cancer and Nutrition using a nested case-control study among 1293 incident CRC-diagnosed cases and 1293 incidence density-matched controls. Conditional logistic regression models controlled for matching factors (age, sex, study center, fasting status, and women-related factors in women) and potential confounders (education, dietary and lifestyle factors, body mass index (BMI), BMI-adjusted waist circumference residuals) were used to estimate relative risks (RRs) and 95% confidence intervals (CIs) for CRC. Higher circulating resistin concentrations were not associated with CRC (RR per doubling resistin, 1.11; 95% CI 0.94–1.30; p = 0.22). There were also no associations with CRC subgroups defined by tumor subsite or sex. However, resistin was marginally associated with a higher CRC risk among participants followed-up maximally two years, but not among those followed-up after more than two years. We observed no substantial correlation between baseline circulating resistin concentrations and adiposity measures (BMI, waist circumference), adipokines (adiponectin, leptin), or metabolic and inflammatory biomarkers (C-reactive protein, C-peptide, high-density lipoprotein cholesterol, reactive oxygen metabolites) among controls. In this large-scale prospective cohort, there was little evidence of an association between baseline circulating resistin concentrations and CRC risk in European men and women. | es_ES |
dc.description.sponsorship | World Health Organization | es_ES |
dc.description.sponsorship | Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London | es_ES |
dc.description.sponsorship | Danish Cancer Society | es_ES |
dc.description.sponsorship | Ligue contre le Cancer (France) | es_ES |
dc.description.sponsorship | Institut Gustave Roussy (France) | es_ES |
dc.description.sponsorship | Mutuelle Generale de l'Education Nationale (France) | es_ES |
dc.description.sponsorship | Institut National de la Sante et de la Recherche Medicale (Inserm) | es_ES |
dc.description.sponsorship | Deutsche Krebshilfe | es_ES |
dc.description.sponsorship | Federal Ministry of Education & Research (BMBF) | es_ES |
dc.description.sponsorship | Hellenic Health Foundation (Greece) | es_ES |
dc.description.sponsorship | Fondazione AIRC per la ricerca sul cancro | es_ES |
dc.description.sponsorship | Consiglio Nazionale delle Ricerche (CNR) | es_ES |
dc.description.sponsorship | Netherlands Government Netherlands Government | es_ES |
dc.description.sponsorship | World Cancer Research Fund International (WCRF) | es_ES |
dc.description.sponsorship | Netherlands Government | es_ES |
dc.description.sponsorship | Nordforsk, Nordic Centre of Excellence programme on Food, Nutrition and Health (Norway) | es_ES |
dc.description.sponsorship | Instituto de Salud Carlos III | es_ES |
dc.description.sponsorship | Junta de Andalucia | es_ES |
dc.description.sponsorship | Principality of Asturias | es_ES |
dc.description.sponsorship | Regional Government of Basque Country (Spain) | es_ES |
dc.description.sponsorship | Regional Government of Murcia (Spain) | es_ES |
dc.description.sponsorship | Regional Government of Navarra (Spain) | es_ES |
dc.description.sponsorship | Instituto de Salud Carlos III RD06/0020 | es_ES |
dc.description.sponsorship | Swedish Cancer Society | es_ES |
dc.description.sponsorship | Swedish Scientific Council (Sweden) | es_ES |
dc.description.sponsorship | Regional Government of Skane and Vasterbotten (Sweden) | es_ES |
dc.description.sponsorship | UK Research & Innovation (UKRI) | es_ES |
dc.description.sponsorship | Medical Research Council UK (MRC) | es_ES |
dc.description.sponsorship | Cancer Research UK | es_ES |
dc.description.sponsorship | Netherlands Government | es_ES |
dc.description.sponsorship | Deutsches Krebsforschungszentrum (Germany) ERC-2009-AdG 232997 | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | MDPI | es_ES |
dc.rights | Atribución 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Pre-diagnostic resistin | es_ES |
dc.subject | Colorectal cancer | es_ES |
dc.subject | Risk | es_ES |
dc.subject | Prospective | es_ES |
dc.subject | Inflammation | es_ES |
dc.title | Pre-Diagnostic Circulating Resistin Concentrations Are Not Associated with Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Study | es_ES |
dc.type | journal article | es_ES |
dc.rights.accessRights | open access | es_ES |
dc.identifier.doi | 10.3390/cancers14225499 | |
dc.type.hasVersion | VoR | es_ES |